These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 24152123

  • 1. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
    Miller AR, Hawkins NA, McCollom CE, Kearney JA.
    Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
    [Abstract] [Full Text] [Related]

  • 2. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA, Zachwieja NJ, Miller AR, Anderson LL, Kearney JA.
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [Abstract] [Full Text] [Related]

  • 3. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA, Calhoun JD, Huffman AM, Kearney JA.
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8.
    Hawkins NA, Speakes N, Kearney JA.
    Mamm Genome; 2024 Sep; 35(3):334-345. PubMed ID: 38862622
    [Abstract] [Full Text] [Related]

  • 8. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
    Anderson LL, Bahceci DA, Hawkins NA, Everett-Morgan D, Banister SD, Kearney JA, Arnold JC.
    PLoS One; 2023 Sep; 18(1):e0280842. PubMed ID: 36701411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.
    Hawkins NA, Kearney JA.
    Epilepsy Res; 2016 Jan; 119():20-3. PubMed ID: 26656780
    [Abstract] [Full Text] [Related]

  • 11. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.
    Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA.
    Epilepsia; 2017 Aug; 58(8):e111-e115. PubMed ID: 28556246
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS, Tang B, Papale LA, Yu FH, Catterall WA, Escayg A.
    Hum Mol Genet; 2007 Dec 01; 16(23):2892-9. PubMed ID: 17881658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
    Yamagata T, Raveau M, Kobayashi K, Miyamoto H, Tatsukawa T, Ogiwara I, Itohara S, Hensch TK, Yamakawa K.
    Neurobiol Dis; 2020 Jul 01; 141():104954. PubMed ID: 32445790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1aA1783V Dravet syndrome mouse model.
    Fadila S, Quinn S, Turchetti Maia A, Yakubovich D, Ovadia M, Anderson KL, Giladi M, Rubinstein M.
    Epilepsia; 2020 Oct 01; 61(10):2289-2300. PubMed ID: 32865826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.